We Support New Ideas

Our mission:
to fund new ideas at their inception

The Society’s independently judged, peer-reviewed research grants are highly valued by researchers and considered important and prestigious within the scientific community.

The Society has funded research projects by most of Canada’s top glaucoma researchers – doctors and scientists interested in finding new treatments and in preventing blindness from glaucoma. These highly respected researchers are recognized across Canada and internationally.

Their research includes:

  • seeking to protect good nerve cells in the eye and repair damaged ones
  • searching for genes related to glaucoma
  • improving blood flow to the eye, and
  • making glaucoma surgery easier for the patient.

80% of funds raised go directly to researchers

Sound governance, a volunteer board, and low administration costs ensure that more than 80% of funds raised by the Society go directly to Canadian researchers.

The Glaucoma Research Society of Canada is the only Canadian non-profit organization solely dedicated to funding glaucoma research. Since 1989, it has raised more than two million dollars in support of 150 research projects. The Society funds 10 to 15% of all independent glaucoma research in Canada.


Glaucoma Research Society of Canada grants $293,000 for 15 research projects in 2017

  • Ptosis after Glaucoma Surgery: A Prospective Study – Dr. Iqbal Ike Ahmed, Dr. Anmol Lamba, Trillium Health Partners, Mississauga, ON
  • First Perspectives and Outcomes with an Ab Interno Gelatin Stent: A Nationwide, Multi-Centre Study – Dr. Iqbal Ike Ahmed, Dr. Matthew Schlenker, Dr. Andrei-Alexandru Szigiato, Trillium Health Partners, Mississauga, ON
  • A Prospective Masked Randomized Study to Evaluate the Effect of Pre-operative Treatment with Topical Brimonidine Tartrate 0.2% (2mg/Ml) Versus Placebo on Intraocular Pressure in Patients Undergoing Robotic-Assisted Radical Laparoscopic Prostatectomy – Dr. Yvonne Buys, Dr. Rana Green, University Health Network, Toronto Western Hospital, Toronto, ON
  • Determining the Role of the Transcription Factor Foxf2 in Eye Development and Glaucoma – Dr. Sarah Childs, Dr. Sarah McFarlane, University of Calgary, Calgary, AB
  • Are Protein Deposits Discovered in the Eyes of Dementia Patients Different from Deposits in Pseudoexfoliation Glaucoma? – Dr. Neeru Gupta, Dr. Yeni Yücel, St. Michael’s Hospital, Toronto, ON
  • Validation of a Novel Bioartificial Tissue Model of Tenon’s Capsule through Whole Transcriptome Comparison with Ex Vivo Tenon’s Capsule and Tenon’s Capsule Fibroblasts in 2D Monolayer Cell Culture – Dr. Cindy Hutnik, Dr. James J. Armstrong, Charles B. Trelford, Honors Thesis Candidate, Ivey Eye Institute, St. Joseph’s Health Centre, London, ON
  • The Effects of Delisting Routine Eye Exams on Glaucoma Detection in Ontario – Dr. Yaping Jin, University of Toronto, Toronto, ON
  • Glaucoma and Ciliary Dysfunction – Dr. Ordan J. Lehmann, University of Alberta, Edmonton, AB
  • Pilot Study on Scleral Rigidity and Choroidal Pulse Volume in Glaucoma Patients with Functional Filtration Blebs: A Window on the Pathophysiology of Glaucoma? – Dr. Mark R. Lesk, University of Montreal, Maisonneuve Rosemont Hospital Research Centre, Montreal, QC
  • Automatic Self Transcending Mediation (ASTM) plus Usual Care Versus Usual Care Alone in Patients with Glaucoma – Dr. Monali Malvankar, Dr. Cindy Hutnik, Ivey Eye Institute, (Lawson Research Institute), St. Joseph’s Hospital, London, ON
  • Glaucoma and Depression: Referral of Patients to CNIB for Support Services – Dr. Victor Penner, Dr. Jennifer Rahman, University of Manitoba, Winnipeg. MB
  • MNK1 as a Novel Neuroprotective Target in RGC Injury – Dr. Jeremy Sivak, Allessandra Tuccitto (Student), University Health Network, Krembil Research Institute, Toronto, ON
  • Comparison of Laser Diode Parameters – Dr. Andrew Toren, Laval University, Quebec, QC
  • Dendritic Retraction and Associated Physiological Responses in Retinal Ganglion Cells in Experimental Glaucoma – Dr. Francois Tremblay, Dr. Balwantray Chauhan, Dalhousie University, Halifax, NS
  • Combination Therapies for the Treatment of Glaucoma – Dr. Catherine Tsilfidis, Ottawa Hospital Research Institute, Ottawa, ON
at work in the lab Dr. Alexander Ball’s 2009 Lab Group

Your donations have funded numerous scientists who have gained international respect and reputations in advancing research into glaucoma.

The next decade should see some important breakthroughs including methods to maintain and possibly even repair damaged optic nerves in glaucoma.

Your support is essential to continue this valuable and much needed research.


Research Grant Applications

Researchers into glaucoma from across Canada apply annually for funding. Independent peers review the applications under the guidance of the Scientific Advisory Committee of renowned ophthalmologists and scientists from across the country. The Committee makes funding recommendations to the Society's Board of Directors.

Applying for a Grant